
LGM Pharma Invests $6M in U.S. Manufacturing for Drug Products
LGM Pharma Invests Over $6M to Expand U.S. Manufacturing Facility in Texas LGM Pharma, a leading provider of tailored Active Pharmaceutical Ingredient (API) and Contract Development and Manufacturing Organization (CDMO) services for the full drug product lifecycle, has announced a…